化学科研者一站式服务平台


  • 艾拉莫德

    N-(7-(Methylsulfonamido)-4-oxo-6-phenoxy-4H-chromen-3-yl)formamide

化合物简介

Iguratimod is an anti-inflammatory drug for the treatment of rheumatoid arthritis. It is approved for use in China and Japan, and is sold by Eisai and Toyama Chemical. Its mechanism of action involves the suppression of nuclear factor-kappa B (NF-κB).

基本信息

CAS:123663-49-0
中文别名:N-(3-甲酰氨基-4-氧-6-苯氧基-4H-色满-7-基)甲烷磺酰胺;N-[3-(甲酰胺基)-4-氧-6-苯氧基-4H-1-苯并吡喃-7-基]甲烷磺酰胺;N-[7-(甲烷磺酰氨基)-4-氧-6-苯氧基-4H-色满-3-基]甲酰胺;
英文别名:N-[7-(Methanesulfonamido)-4-oxo-6-phenoxy-4H-chromen-3-yl]formamide;N-[7-(methanesulfonamido)-4-oxo-6-phenoxychromen-3-yl]formamide;N-(3-Formamido-4-oxo-6-phenoxy-4H-chromen-7-yl)methanesulfonamide;
分子式:C17H14N2O6S
分子量:374.368
精确质量:374.057
Psa:123.09
Logp:4.3878

编号系统

UNII:4IHY34Y2NV

物化性质

外观与性状:白色粉末
密度:1.52 g/cm3
沸点:580.6ºC at 760 mmHg
闪点:304.9ºC
折射率:1.673
蒸汽压:1.8E-13mmHg at 25°C

安全信息

海关编码:2935009090

生产方法及用途

合成路线

上游原料

下游产品

图谱

13C NMR : Predict


1H NMR : Predict


加载中...